IVVD

Invivyd, Inc. - Common Stock (IVVD)

About Invivyd, Inc. - Common Stock (IVVD)

Invivyd, Inc. engages in the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The firm develops antibodies that can neutralize SARS-CoV-2, SARS-CoV-1, and additional emergent coronaviruses. It offers, ADG20, a monoclonal antibody targeting the spike protein of SARS-CoV-2 and related coronaviruses. The company was founded by Tillman U. Gerngross, Ren Russo and Laura Walker on June 3, 2020 and is headquartered in Waltham, MA.

Details

Daily high

$0.69

Daily low

$0.62

Price at open

52 Week High

$2.74

52 Week Low

$0.35

Market cap

76.2M

Dividend yield

0.00%

Volume

699

Avg. volume

1.4M

P/E ratio

-.44

Invivyd, Inc. - Common Stock News